Vaccines Strategies to Prevent Covid-19 and Combination Immunotherapy with a Cancer Vaccine
Tuesday, June 23, 2020
12:15pm, Zoom live internet conference
VACCINE UPDATE: CORONAVIRUS AND ONCOLOGY TRIALS
BERNARD A. FOX, PHD
HARDER FAMILY CHAIR FOR CANCER RESEARCH
MEMBER AND CHIEF, LABORATORY OF MOLECULAR AND TUMOR IMMUNOLOGY,
PROVIDENCE PORTLAND MEDICAL CENTER
Planner/Moderator:
Ora Gordon, MD, MS; Regional Med. Dir., Center for Clinical Genetics & Genomics; Med. Dir., Integrative Medicine, Roy and Patricia Disney Family Cancer Center
Planner/Faculty Disclosures:
It is our policy to ensure that planners, faculty and content are independent of commercial bias. Dr. Gordon states she has no financial arrangements nor affiliations with any commercial company to disclose. In managing a possible conflict of interest, Dr. Fox shares the following:
“As part of my conflict of Interest management program with Providence, I disclose all of my potential COI in my second slide – every time I speak. Typically I disclose anything within a 3 to 5 year time frame. In response to this form I limited the companies to the last 12 months.
UbiVac is a biotech spun-out of Providence. I am a Founder and the uncompensated (no salary) CEO of UbiVac. I am a 0.9FTE of Providence.
UbiVac is manufacturing the COVID-19 vaccine for the Providence sponsored Investigational New Drug application submitted to run the vaccine clinical trial.
UbiVac is also manufacturing the vaccine for a multicenter breast cancer vaccine trial that is being sponsored by BMS and led by a Providence breast oncologist.
I will talk about the COVID-19 vaccine trials as well as the Providence COVID-19 vaccine trial, cancer research, the monitoring of the immune response to cancer, monitoring trials and the clinical trials that are just starting.”
Disclosures for members of the Medical Education Committee may be found on the CME website at
www.providencecme.org.
Click Here For Learning Objectives
Release Date: 09-4-20
Review Date: 09/23
Termination Date:
Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|
|
6/23/2020
|
|
Bernard
Fox,
PhD.
|
|
Presenter
|
|
Hope Conference Center
|
|
|
Complete Video Confirmation
In order to complete the evaluation, you must log in.
|
|
|
|
|
|
|
|
AI: Artificial Intelligence in Medicine and Radiology
|
|
THURSDAY, November 9, 2023
12:15pm-- Zoom Live Internet Activity
ARTIFICIAL INTELLIGENCE IN MEDICINE
GEOFFREY TSO, MD
ASSISTANT CLINICAL PROFESSOR, STANFORD UNIVERSITY SCHOOL OF MEDICINE
PRIMARY CARE AND POPULATION HEALTH
Moderator: Ronald Ruby, MD, Director Medical Education Providence Little Company of Mary, Co-Director Cardiometabolic Center Providence Little Company of Mary
Planners: This activity was originally planned by the Health Education Committee of Providence Little Company of Mary, Torracne.
FACULTY/PLANNER DISCLOSURES: It is our policy to ensure that planners, faculty, and content are independent of commercial bias. Dr. Tso states he has had no financial relationships nor affiliations with any ineligible companies in the past 24 months. Disclosures for members of the PSJMC Medical Education Committee may be found at https://providencecme.org No CME Committee member has had any financial relationships nor affiliations with any ineligible companies in the past 24 months.
Learning Objectives
Release Date: 11/23
Review Date: 11/26
Termination Date:
Providence Saint Joseph Medical Center is accredited by California Medical Association (CMA) to provide continuing medical education for physicians.
Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This credit may also be applied to the CMA Certification in Continuing Medical Education.
|
|
|
|
Triple Threat: COVID, Flu, RSV- Where we are now, what is predicted_
|
|
TUESDAY, November 7, 2023
12:15pm –Hybrid: In-person, Zoom Live Internet Activity
QUARTERLY EPIDEMIOLOGY UPDATE: TRIPLE THREAT: COVID, FLU, RSV
SHIRA SHAFIR, PH.D., MPH
ASSOCIATE PROFESSOR, COMMUNITY HEALTH SCIENCES AND EPIDEMIOLOGY
UCLA FIELDING SCHOOL OF PUBLIC HEALTH
Planner/Moderator: Karen Tsujimoto, M.D., Medical Director, Infection Prevention
Providence Saint Joseph Medical Center
FACULTY/PLANNER DISCOSURES: It is our policy to ensure that planners, faculty, and content are independent of commercial bias. Drs. Tsujimoto and Shafir disclose they have had no financial relationships nor affiliations with any ineligible companies in the last 24 months. Disclosures for members of the PSJMC Medical Education Committee may be found on the CME website at https://providencecme.org. Committee members disclose they have had no financial relationships nor affiliations with any ineligible companies in the last 24 months.
Learning Objectives
Release Date: 11/23
Review Date: 11/26
Termination Date:
Providence Saint Joseph Medical Center is accredited by California Medical Association (CMA) to provide continuing medical education for physicians.
Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This credit may also be applied to the CMA Certification in Continuing Medical Education.
Providence Saint Joseph Medical Center is accredited by California Medical Association (CMA) to provide continuing medical education for physicians.
Providence Saint Joseph Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This credit may also be applied to the CMA Certification in Continuing Medical Education.
|
|
|
|
|